Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 2.065
-0.115 (-5.28%)
Jun 16, 2026, 5:01 PM CET
Pure Biologics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
26.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 662.00K | 408.00K | 160.63% |
| Dec 31, 2021 | 254.00K | -318.00K | -55.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 266.02M |
| Ryvu Therapeutics | 88.38M |
| Synthaverse | 42.19M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Urteste | 2.50M |
| Pharmena | 1.61M |
| Poltreg | 250.00K |